Ofir Levy

Ofir Levy

Auto-generated profile, based on publicly available information

Ofir Levy

Department of Neurology, Tel Aviv Sourasky University Medical Center, Israel

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2021 in Journal of Gynecology Obstetrics and Human Reproduction
Verified
Journal Article
Closed access
LALiad Alfandari
Liad Alfandari
GPGali Pariente
Gali Pariente
DYDavid Yohay
David Yohay
OLOfir Levy
Ofir Levy
AWAdi Y. Weintraub
Adi Y. Weintraub
R0Reut Rotem (ORCID - 0000-0002-4063-5911)
Reut Rotem (ORCID - 0000-0002-4063-5911)

1 September 2026 in Neurology Neuroimmunology & Neuroinflammation
Verified
Journal Article
Open access
PDF file
AGAvi Gadoth
Avi Gadoth
YPYael Paran
Yael Paran
YMYair Mina
Yair Mina
OLOfir Levy
Ofir Levy
TSTamir Shragai
Tamir Shragai
DHDavid Hagin
David Hagin
Background and ObjectivesBispecific antibodies (BisAbs) have transformed the management of relapsed and refractory multiple myeloma (MM), achieving high response rates in heavily pretreated patient...

12 November 2026 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
OLOfir Levy
Ofir Levy
AAAvshalom Ashirie
Avshalom Ashirie
EPElizaveta Pustovoyt
Elizaveta Pustovoyt
DZDaniel Zarhin
Daniel Zarhin
MHMuhamad Hawwari
Muhamad Hawwari
AGAvi Gadoth
Avi Gadoth
Objective: West Nile Virus (WNV), a prominent arbovirus, is known for its potential to cause severe neurological complications. In the summer of 2024, Israel experienced a WNV outbreak, with 930 confirmed cases reported and a mortality rate of 7.8%. Although gastrointestinal manifestations such as diarrhea, nausea and vomiting are well known disease manifestations, we noticed there were patients who developed intestinal pseudo-obstruction which is not a known complication of WNV. Methods: We retrospectively reviewed medical records of patients diagnosed with WNV disease at the Tel-Aviv Sourasky Medical Center during the 2024 outbreak. Demographics, clinical characteristics, imaging and outcomes were collected and compared between patients with and without intestinal pseudo-obstruction (IPO). Results: Between June and October 2024, 105 patients were hospitalized at our institution with acute WNV infection. Eight of them (7.6%) developed severe constipation, with little to no response to laxative treatments. All eight patients exhibited clinical signs consistent with IPO. Of these eight patients, two (25%) died due to complications related to the pseudo-obstruction, compared with 10.6% overall mortality among hospitalized patients with WNV disease in our institution. Five out of the 8 IPO patients (62.5%) had flaccid paralysis compared to 13 (13.4%) of the non-IPO WNV infected patients. Interpretation: This study highlights intestinal pseudo-obstruction as a complication in hospitalized patients with WNV infection. IPO was associated with neuroinvasive disease and increased morbidity and mortality. Awareness and early management of this complication may improve patient outcomes.